FI63947C - Foerfarande foer framstaellning av farmakologiskt vaerdefulla 3,20-dioxo-7alfa-halogen-4-pregnener och 1,4-pregnadiener - Google Patents
Foerfarande foer framstaellning av farmakologiskt vaerdefulla 3,20-dioxo-7alfa-halogen-4-pregnener och 1,4-pregnadiener Download PDFInfo
- Publication number
- FI63947C FI63947C FI773825A FI773825A FI63947C FI 63947 C FI63947 C FI 63947C FI 773825 A FI773825 A FI 773825A FI 773825 A FI773825 A FI 773825A FI 63947 C FI63947 C FI 63947C
- Authority
- FI
- Finland
- Prior art keywords
- dione
- methyl
- group
- halogen
- chloro
- Prior art date
Links
Classifications
-
- E—FIXED CONSTRUCTIONS
- E04—BUILDING
- E04G—SCAFFOLDING; FORMS; SHUTTERING; BUILDING IMPLEMENTS OR AIDS, OR THEIR USE; HANDLING BUILDING MATERIALS ON THE SITE; REPAIRING, BREAKING-UP OR OTHER WORK ON EXISTING BUILDINGS
- E04G11/00—Forms, shutterings, or falsework for making walls, floors, ceilings, or roofs
- E04G11/06—Forms, shutterings, or falsework for making walls, floors, ceilings, or roofs for walls, e.g. curved end panels for wall shutterings; filler elements for wall shutterings; shutterings for vertical ducts
- E04G11/20—Movable forms; Movable forms for moulding cylindrical, conical or hyperbolical structures; Templates serving as forms for positioning blocks or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J21/001—Lactones
- C07J21/003—Lactones at position 17
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
- C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
- C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
- C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
- C07J5/0084—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkylene group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
- C07J7/0045—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
- C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/0026—Oxygen-containing hetero ring cyclic ketals
- C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
-
- E—FIXED CONSTRUCTIONS
- E04—BUILDING
- E04G—SCAFFOLDING; FORMS; SHUTTERING; BUILDING IMPLEMENTS OR AIDS, OR THEIR USE; HANDLING BUILDING MATERIALS ON THE SITE; REPAIRING, BREAKING-UP OR OTHER WORK ON EXISTING BUILDINGS
- E04G17/00—Connecting or other auxiliary members for forms, falsework structures, or shutterings
- E04G17/14—Bracing or strutting arrangements for formwalls; Devices for aligning forms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Architecture (AREA)
- Mechanical Engineering (AREA)
- Civil Engineering (AREA)
- Structural Engineering (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Rheumatology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US75325676A | 1976-12-22 | 1976-12-22 | |
US75325776 | 1976-12-22 | ||
US05/753,257 US4076708A (en) | 1976-12-22 | 1976-12-22 | Process for the preparation of 7α-halogeno-3-oxo-4-dehydro steroids and novel 7α-halogeno derivatives produced thereby |
US75325676 | 1976-12-22 |
Publications (3)
Publication Number | Publication Date |
---|---|
FI773825A FI773825A (fi) | 1978-06-23 |
FI63947B FI63947B (fi) | 1983-05-31 |
FI63947C true FI63947C (fi) | 1983-09-12 |
Family
ID=27115720
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI773825A FI63947C (fi) | 1976-12-22 | 1977-12-19 | Foerfarande foer framstaellning av farmakologiskt vaerdefulla 3,20-dioxo-7alfa-halogen-4-pregnener och 1,4-pregnadiener |
Country Status (20)
Country | Link |
---|---|
JP (1) | JPS604198B2 (da) |
AR (1) | AR226806A1 (da) |
AT (2) | AT373269B (da) |
BE (1) | BE862089A (da) |
DE (1) | DE2756550C2 (da) |
DK (1) | DK153494C (da) |
FI (1) | FI63947C (da) |
FR (1) | FR2384793A1 (da) |
GB (1) | GB1575983A (da) |
HK (1) | HK584A (da) |
HU (1) | HU179784B (da) |
IE (1) | IE45950B1 (da) |
IL (1) | IL53636A (da) |
MY (1) | MY8500082A (da) |
NL (1) | NL180479C (da) |
NO (1) | NO151826C (da) |
NZ (1) | NZ186031A (da) |
PT (1) | PT67432B (da) |
SE (1) | SE429865B (da) |
SG (1) | SG58683G (da) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109680036A (zh) | 2017-10-02 | 2019-04-26 | 爱科来株式会社 | 糖化蛋白质的测定 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3429926A (en) * | 1964-05-25 | 1969-02-25 | Squibb & Sons Inc | 7-halo and 6-halo,6-dehydro a-norprogesterones |
-
1977
- 1977-12-13 GB GB51805/77A patent/GB1575983A/en not_active Expired
- 1977-12-19 PT PT67432A patent/PT67432B/pt unknown
- 1977-12-19 AT AT0909477A patent/AT373269B/de not_active IP Right Cessation
- 1977-12-19 FI FI773825A patent/FI63947C/sv not_active IP Right Cessation
- 1977-12-19 AR AR270418A patent/AR226806A1/es active
- 1977-12-19 NL NLAANVRAGE7714056,A patent/NL180479C/xx not_active IP Right Cessation
- 1977-12-19 JP JP52152835A patent/JPS604198B2/ja not_active Expired
- 1977-12-19 FR FR7738297A patent/FR2384793A1/fr active Granted
- 1977-12-19 IL IL53636A patent/IL53636A/xx unknown
- 1977-12-19 NO NO774359A patent/NO151826C/no unknown
- 1977-12-19 DE DE2756550A patent/DE2756550C2/de not_active Expired
- 1977-12-19 IE IE2576/77A patent/IE45950B1/en not_active IP Right Cessation
- 1977-12-19 NZ NZ186031A patent/NZ186031A/en unknown
- 1977-12-20 BE BE183654A patent/BE862089A/xx not_active IP Right Cessation
- 1977-12-20 SE SE7714538A patent/SE429865B/sv not_active IP Right Cessation
- 1977-12-20 DK DK569977A patent/DK153494C/da not_active IP Right Cessation
- 1977-12-21 HU HU77SCHE635A patent/HU179784B/hu unknown
-
1980
- 1980-11-25 AT AT0575980A patent/AT377566B/de not_active IP Right Cessation
-
1983
- 1983-09-09 SG SG586/83A patent/SG58683G/en unknown
-
1984
- 1984-01-05 HK HK5/84A patent/HK584A/xx not_active IP Right Cessation
-
1985
- 1985-12-30 MY MY82/85A patent/MY8500082A/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4124707A (en) | 7α-Halogeno-3,20-dioxo-1,4-pregnadienes, methods for their manufacture, their use as anti-inflammatory agents, and pharmaceutical formulations useful therefor | |
US4242334A (en) | Corticoid 17-(alkyl carbonates) and processes for their preparation | |
FI80888C (fi) | Foerfarande foer framstaellning av terapeutiskt verkande steroida karboxylsyraestrar. | |
US4076708A (en) | Process for the preparation of 7α-halogeno-3-oxo-4-dehydro steroids and novel 7α-halogeno derivatives produced thereby | |
US4267173A (en) | Use of 6β-fluoro-7α-halogenocorticoids as topical anti-inflammatories and pharmaceutical formulations useful therefor | |
CS203956B2 (en) | Method of producing derivatives of 3-oxoandrostene /or androstadiene/ thiocarboxylic acid | |
US4172132A (en) | 1,3,5(10),6,8,14-19-Nor-pregnahexaenes, their use as anti-psoriatic agents, and pharmaceutical formulations useful therefor | |
CS209916B2 (en) | Method of making the esters of 4-halogen-9-fluor-3-oxoandrost-4en and 4-halogen-9-fluor-3-oxoandrosta-1,4-dien-17 beta-thiocarboxyl acid | |
WO1983003099A1 (en) | 3-keto-delta 4,9-19-norsteroids | |
US4619921A (en) | Polyhalogeno-steroids | |
JPH0641187A (ja) | 17−位において置換されたコルチコイド−17−アルキルカーボネート、その製法およびそれらを含有する薬学的組成物 | |
FI69474C (fi) | Foerfarande att framstaella anti-inflammatoriska 6alfa-fluor-9alfa-klor-prednisolon 17,21-diestrar | |
FI63947C (fi) | Foerfarande foer framstaellning av farmakologiskt vaerdefulla 3,20-dioxo-7alfa-halogen-4-pregnener och 1,4-pregnadiener | |
EP0001864A1 (en) | Novel 6-oxygenated-3,20-dioxo-pregnane derivatives, process for the preparation thereof, and pharmaceutical compositions containing them | |
US7479486B2 (en) | Sulphur analogues of 21-hydroxy-6,19-oxidoprogesterone (21OH-6OP) for treating excess of glucocorticoids | |
CA1101410A (en) | Polyhalogenated steroids | |
US4185101A (en) | 1,3,5(10),6,8-19-Nor-pregnapentaenes, their use as anti-psoriatic agents, and pharmaceutical formulations useful therefor | |
Toscano et al. | Synthesis and topical antiinflammatory properties of 17, 21-bis (acetyloxy)-6. beta., 9-difluoro-11. beta.-hydroxypregna-1, 4-diene-3, 20-dione and related 2-halogenated compounds | |
KR810000311B1 (ko) | 7-할로-3,20-디옥소-1,4-프레그나디엔 및 -4-프레그넨의 제조 방법 | |
US3980680A (en) | Process for the preparation of 21-desoxy-17-acyloxy-4-pregnenes and of 21-iodo-21-desoxy-17-acyl oxy-4-pregnene intermediates useful therein | |
US3931167A (en) | Process for the manufacture of 3-keto-6-azido-4,6-bis-dehydro-steroids and intermediates useful therein | |
EP0000609B1 (en) | Novel 19-nor-pregnahexaenes, process for the preparation thereof, and pharmaceutical compositions containing them | |
AU2001289889B2 (en) | Sulphur analogues of 21-hydroxy-6,19-oxidoprogesterone (21oh-6op) for treating excess of glucocorticoids | |
KR800000555B1 (ko) | 스테로이드의 레티온산 에스테르의 제조방법 | |
KR840000155B1 (ko) | 6α, 9α-디플루오로-16-메틸-프레드니솔론 17, 21-디에스테르의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MA | Patent expired | ||
MA | Patent expired |
Owner name: SCHERING CORPORATION |